Research And Markets Research And Markets
0 CHECKOUT

Turkey Pharmaceuticals and Healthcare Report Q1 2016

  • ID: 3526541
  • January 2016
  • Region: Turkey
  • 97 pages
  • Business Monitor International
1 of 4

FEATURED COMPANIES

  • Abdi Ibrahim
  • EastPharma (Deva)
  • Eczacibasi Healthcare
  • Sanovel Pharmaceuticals
  • MORE

A strong health care sector and more certain drug pricing policy will drive pharmaceutical sales in value terms over the next 10 years and improve the commercial opportunities for pharmaceutical manufacturers. Despite this positive development, cost containment measures will remain a risk, as will the political situation with neighbouring Syria and nearby Russia.

Headline Expenditure Projections
- Pharmaceuticals: TRY18.72bn (USD8.56bn) in 2014 to TRY20.81bn (USD7.38bn) in 2015; +11.1% in local currency and -13.8% US dollar terms. Forecast unchanged in local currency and down in US dollars compared with previous quarter due to revised exchange rate expectations.

- Healthcare: TRY95.78bn (USD43.78bn) in 2014 to TRY107.17bn (USD38.01bn) in 2015; +11.9% in local currency and -13.2% US dollar terms. Forecast unchanged in local currency and down in US dollars compared with previous quarter due to revised exchange rate expectations.

Note: Product cover images may vary from those shown
2 of 4

FEATURED COMPANIES

  • Abdi Ibrahim
  • EastPharma (Deva)
  • Eczacibasi Healthcare
  • Sanovel Pharmaceuticals
  • MORE

Table: Headline Pharmaceuticals & Healthcare Forecasts (Turkey 2013-2019)

SWOT

Industry Forecast

Pharmaceutical Market Forecast
Table: Pharmaceutical Sales, Historical Data And Forecasts (Turkey 2011-2019)

Healthcare Market Forecast
Table: Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2011-2019)
Table: Government Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2011-2019)
Table: Private Healthcare Expenditure Trends, Historical Data And Forecasts (Turkey 2011-2019)

Prescription Drug Market Forecast
Table: Prescription Drug Market Indicators, Historical Data And Forecasts (Turkey 2011-2019)

Patented Drug Market Forecast
Table: Patented Drug Market Indicators, Historical Data And Forecasts (Turkey 2011-2019)

Generic Drug Market Forecast
Table: Generic Drug Market Indicators, Historical Data And Forecasts (Turkey 2011-2019)

OTC Medicine Market Forecast
Table: Over-The-Counter (OTC) Medicine Market Indicators, Historical Data And Forecasts (Turkey 2011-2019)

Pharmaceutical Trade Forecast
Table: Pharmaceutical Trade Data And Forecasts (Turkey 2013-2019)
Table: Pharmaceutical Trade Data And Forecasts local currency (Turkey 2013-2019)

Industry Risk/Reward Index

Central And Eastern Europe Risk/Reward Index - Q1 2016

Turkey Risk/Reward Index

Rewards

Risks

Regulatory Review

Intellectual Property Regime

Market Access Issues

Pricing Regime
Table: Turkish Pharmaceutical Pricing Decrees

Reimbursement Regime
Table: Pharmacist Discount Related To Annual Sales Revenue (VAT Excluded)

Market Overview

Market Overview

Epidemiology

Healthcare Sector

Health Insurance

Healthcare Infrastructure

Healthcare Financing
Table: Healthcare Resources (Turkey 2009-2014)
Table: Healthcare Personnel (Turkey 2009-2014)
Table: Healthcare Activity (Turkey 2009-2014)

Research & Development

Clinical Trials

Competitive Landscape

Pharmaceutical Sector

Research-Based Industry

Generic Drugmakers

Company Activity
Table: Multinational Market Activity

Pharmaceutical Distribution

Pharmaceutical Retail

Company Profile

Abdi Ibrahim

EastPharma (Deva)

Eczacibasi Healthcare

Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals

Sanovel Pharmaceuticals

Demographic Forecast
Table: Population Headline Indicators (Turkey 1990-2025)
Table: Key Population Ratios (Turkey 1990-2025)
Table: Urban/Rural Population & Life Expectancy (Turkey 1990-2025)
Table: Population By Age Group (Turkey 1990-2025)
Table: Population By Age Group % (Turkey 1990-2025)

Glossary

Methodology

Pharmaceutical Expenditure Forecast Model

Healthcare Expenditure Forecast Model

Notes On Methodology

Risk/Reward Index Methodology

Index Overview
Table: Pharmaceutical Risk/Reward Index Indicators

Indicator Weightings

Note: Product cover images may vary from those shown
3 of 4

Abdi Ibrahim
EastPharma (Deva)
Eczacibasi Healthcare
Mustafa Nevzat Ilac Sanayi (MN) Pharmaceuticals
Sanovel Pharmaceuticals

Note: Product cover images may vary from those shown
4 of 4
Note: Product cover images may vary from those shown

RELATED PRODUCTS from Db